[HTML][HTML] Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong… - Nature …, 2020 - nature.com
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
and therapeutics will depend on understanding viral immunity. We studied T cell memory …
and therapeutics will depend on understanding viral immunity. We studied T cell memory …
[HTML][HTML] Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease
…, L Liang, J Sun, B Xu, Y Dai, X Li, C Zhang, Y Peng… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND. Identifying immune correlates of COVID-19 disease severity is an urgent
need for clinical management, vaccine evaluation, and drug development. Here, we present a …
need for clinical management, vaccine evaluation, and drug development. Here, we present a …
[HTML][HTML] Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. …
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. …
[HTML][HTML] SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
…, L Xu, C Wang, L Chen, X Xiao, Y Peng… - The Lancet …, 2022 - thelancet.com
Background The memory immune response is crucial for preventing reinfection or reducing
disease severity. However, the robustness and functionality of the humoral and T-cell …
disease severity. However, the robustness and functionality of the humoral and T-cell …
[PDF][PDF] A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete
description of specific immune biomarkers. We present here a comprehensive multi-omic …
description of specific immune biomarkers. We present here a comprehensive multi-omic …
[HTML][HTML] An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Y Peng, SL Felce, D Dong, F Penkava, AJ Mentzer… - Nature …, 2022 - nature.com
NP 105–113 -B*07:02-specific CD8 + T cell responses are considered among the most
dominant in SARS-CoV-2-infected individuals. We found strong association of this response with …
dominant in SARS-CoV-2-infected individuals. We found strong association of this response with …
[PDF][PDF] The antigenic anatomy of SARS-CoV-2 receptor binding domain
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
Preliminary assessment of the efficacy of a t-cell–based influenza vaccine, MVA-NP+ M1, in humans
…, AJ Spencer, M Hamill, Y Peng… - Clinical infectious …, 2012 - academic.oup.com
Background. The novel influenza vaccine MVA-NP+M1 is designed to boost cross-reactive T-cell
responses to internal antigens of the influenza A virus that are conserved across all …
responses to internal antigens of the influenza A virus that are conserved across all …
[HTML][HTML] Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children
…, AM Leese, AI Bell, KA McAulay, P Yanchun… - PLoS …, 2015 - journals.plos.org
Epstein-Barr virus (EBV) infection often occurs in early childhood and is asymptomatic.
However, if delayed until adolescence, primary infection may manifest as acute infectious …
However, if delayed until adolescence, primary infection may manifest as acute infectious …
[HTML][HTML] High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection
Background Dengue is one of the most important human diseases transmitted by an arthropod
vector and the incidence of dengue virus infection has been increasing – over half the …
vector and the incidence of dengue virus infection has been increasing – over half the …